GlassScriptPhysician profile
Marc Slonimski
NPI 1891700522
$15,872.27
in general payments reported to CMS, 2019-2025
31 companies · $1,190 in 2025
The $1,190 reported for 2025 was more than what 76% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,026 · 2020: $828 · 2021: $1,250 · 2022: $2,139 · 2023: $6,221 · 2024: $2,218 · 2025: $1,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,385 · Consulting Fee: $4,000 · Travel and Lodging: $226 · Education: $17.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,385.35 |
| Consulting Fee | $4,000.00 |
| Travel and Lodging | $225.87 |
| Education | $17.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $4,249.95 | 2023-2025 | |
| Medtronic, INC. | $2,638.04 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Osteocool Rf Ablation System |
| Abbott Laboratories | $2,626.10 | 2019-2025 | Eterna, Proclaim |
| Vertiflex, INC. | $1,220.73 | 2019 | |
| Relievant Medsystems, INC. | $644.19 | 2023 | Intracept |
| Boston Scientific Corporation | $623.81 | 2019-2025 | Intracept, General - Pain Management, Superion Indirect Decompression System |
| Vertos Medical, INC. | $604.67 | 2019-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $426.34 | 2022-2025 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $412.19 | 2019-2024 | Relistor |
| Spinal Simplicity, LLC | $325.02 | 2024-2025 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $254.31 | 2023 | |
| Saluda Medical Americas, INC. | $232.86 | 2024-2025 | Evoke |
| Nalu Medical, INC. | $214.85 | 2021-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $206.42 | 2019-2024 | Senza |
| Curonix LLC | $160.34 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $147.58 | 2023-2025 | Prospera, Biotronik |
| Abbvie INC. | $143.56 | 2021-2024 | |
| Mml US, INC. | $111.22 | 2025 | Reactiv8 |
| Redhill Biopharma INC. | $97.59 | 2020-2021 | |
| Stryker Corporation | $97.51 | 2023 | Augment Injectable |
| Depuy Synthes Sales INC. | $95.72 | 2023-2024 | Orthovisc |
| Electronic Waveform Lab, INC. | $80.00 | 2021 | |
| Stimwave Technologies Incorporated | $54.03 | 2021 | |
| Tersera Therapeutics LLC | $52.62 | 2025 | Prialt |
| Zyla Life Sciences, INC. | $36.49 | 2019-2020 | |
| Valinor Pharma, LLC | $30.47 | 2025 | Movantik |
| Averitas Pharma INC. | $23.38 | 2023 | Qutenza |
| Pacira Therapeutics, INC. | $21.34 | 2019 | |
| Sentynl Therapeutics, INC. | $14.59 | 2019 | |
| Hikma Pharmaceuticals USA | $13.77 | 2022 | |
| Radius Health, INC. | $12.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Slonimski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.